New Kid On The Block: Pfizer/Pharmacia Merger Points To Drug-Device Play
This article was originally published in The Gray Sheet
Executive Summary
Pfizer will leverage its acquisition of Pharmacia to carve out a combination drug-device business to support its needle-less insulin delivery initiatives